Skip to main content
Erschienen in: Inflammation 2/2015

01.04.2015

Genetic Variants of Interleukin 17A Are Functionally Associated with Increased Risk of Age-Related Macular Degeneration

verfasst von: Shaoru Zhang, Yonghua Liu, Shilin Lu, Xinmeng Cai

Erschienen in: Inflammation | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in elderly populations worldwide. Inflammation, among many factors, has been suggested to play an important role in AMD pathogenesis. Interleukin 17 (IL-17) is a proinflammatory cytokine that has been implicated in the pathogenesis of various autoimmune diseases. In the current study, we examined two single nucleotide polymorphisms (SNPs), rs2275913G/A and rs3748067C/T, in the IL-17A gene between AMD patients and healthy controls. Results showed that rs2275913AA genotype and rs3748067TT genotype were associated with increased susceptibility to AMD (hazard ratio [HR], 1.75; 95 % confidence interval [CI], 1.07 to 3.02; P = 0.023, and HR, 2.12; 95 % CI, 1.26 to 4.01; P = 0.004; data were adjusted for age and sex). Next, we investigated the functional relevance of the two SNPs. In vitro stimulated peripheral blood mononuclear cells (PBMCs) from subjects possessing the rs2275913AA genotype produced significantly more IL-17 than those with the GG genotype. However, PBMCs with rs3748067TT genotype revealed significantly higher IL-17 production than those with rs3748067CC genotype only in AMD patients but not in controls. These data indicate IL-17A polymorphisms are associated with increased risk of AMD probably by affecting gene expression.
Literatur
1.
Zurück zum Zitat Ardeljan, D., Y. Wang, S. Park, D. Shen, X.K. Chu, C.R. Yu, M. Abu-Asab, J. Tuo, C.G. Eberhart, T.W. Olsen, R.F. Mullins, G. White, S. Wadsworth, A. Scaria, and C.C. Chan. 2014. Interleukin-17 retinotoxicity is prevented by gene transfer of a soluble interleukin-17 receptor acting as a cytokine blocker: implications for age-related macular degeneration. PLoS One 9: e95900.PubMedCentralPubMedCrossRef Ardeljan, D., Y. Wang, S. Park, D. Shen, X.K. Chu, C.R. Yu, M. Abu-Asab, J. Tuo, C.G. Eberhart, T.W. Olsen, R.F. Mullins, G. White, S. Wadsworth, A. Scaria, and C.C. Chan. 2014. Interleukin-17 retinotoxicity is prevented by gene transfer of a soluble interleukin-17 receptor acting as a cytokine blocker: implications for age-related macular degeneration. PLoS One 9: e95900.PubMedCentralPubMedCrossRef
2.
Zurück zum Zitat Bar, E., P.G. Whitney, K. Moor, C. Reis, E. Sousa, and S. LeibundGut-Landmann. 2014. IL-17 regulates systemic fungal immunity by controlling the functional competence of NK cells. Immunity 40: 117–127.PubMedCrossRef Bar, E., P.G. Whitney, K. Moor, C. Reis, E. Sousa, and S. LeibundGut-Landmann. 2014. IL-17 regulates systemic fungal immunity by controlling the functional competence of NK cells. Immunity 40: 117–127.PubMedCrossRef
3.
Zurück zum Zitat Benedetti, G., and P. Miossec. 2014. Interleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritis. European Journal of Immunology 44: 339–347.PubMedCrossRef Benedetti, G., and P. Miossec. 2014. Interleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritis. European Journal of Immunology 44: 339–347.PubMedCrossRef
4.
Zurück zum Zitat Blasiak, J., G. Petrovski, Z. Vereb, A. Facsko, and K. Kaarniranta. 2014. Oxidative stress, hypoxia, and autophagy in the neovascular processes of age-related macular degeneration. BioMed Research International 2014: 768026.PubMedCentralPubMedCrossRef Blasiak, J., G. Petrovski, Z. Vereb, A. Facsko, and K. Kaarniranta. 2014. Oxidative stress, hypoxia, and autophagy in the neovascular processes of age-related macular degeneration. BioMed Research International 2014: 768026.PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Espinoza, J.L., A. Takami, K. Nakata, M. Onizuka, T. Kawase, H. Akiyama, K. Miyamura, Y. Morishima, T. Fukuda, Y. Kodera, and S. Nakao. 2011. A genetic variant in the IL-17 promoter is functionally associated with acute graft-versus-host disease after unrelated bone marrow transplantation. PLoS One 6: e26229.PubMedCentralPubMedCrossRef Espinoza, J.L., A. Takami, K. Nakata, M. Onizuka, T. Kawase, H. Akiyama, K. Miyamura, Y. Morishima, T. Fukuda, Y. Kodera, and S. Nakao. 2011. A genetic variant in the IL-17 promoter is functionally associated with acute graft-versus-host disease after unrelated bone marrow transplantation. PLoS One 6: e26229.PubMedCentralPubMedCrossRef
6.
Zurück zum Zitat Frleta, M., S. Siebert, and I.B. McInnes. 2014. The interleukin-17 pathway in psoriasis and psoriatic arthritis: disease pathogenesis and possibilities of treatment. Current Rheumatology Reports 16: 414.PubMedCrossRef Frleta, M., S. Siebert, and I.B. McInnes. 2014. The interleukin-17 pathway in psoriasis and psoriatic arthritis: disease pathogenesis and possibilities of treatment. Current Rheumatology Reports 16: 414.PubMedCrossRef
7.
Zurück zum Zitat Gu, C., L. Wu, and X. Li. 2013. IL-17 family: cytokines, receptors and signaling. Cytokine 64: 477–485.PubMedCrossRef Gu, C., L. Wu, and X. Li. 2013. IL-17 family: cytokines, receptors and signaling. Cytokine 64: 477–485.PubMedCrossRef
8.
Zurück zum Zitat Hayashi, R., T. Tahara, H. Shiroeda, T. Saito, M. Nakamura, M. Tsutsumi, T. Shibata, and T. Arisawa. 2013. Influence of IL17A polymorphisms (rs2275913 and rs3748067) on the susceptibility to ulcerative colitis. Clinical and Experimental Medicine 13: 239–244.PubMedCrossRef Hayashi, R., T. Tahara, H. Shiroeda, T. Saito, M. Nakamura, M. Tsutsumi, T. Shibata, and T. Arisawa. 2013. Influence of IL17A polymorphisms (rs2275913 and rs3748067) on the susceptibility to ulcerative colitis. Clinical and Experimental Medicine 13: 239–244.PubMedCrossRef
9.
Zurück zum Zitat Kerami, Z., N.W. Duijvis, E.W. Vogels, F.H. van Dooren, P.D. Moerland, and A.A. Te Velde. 2014. Effect of interleukin-17 on gene expression profile of fibroblasts from Crohn’s disease patients. Journal of Crohn’s & Colitis. doi:10.1016/j.crohns.2014.02.009. Kerami, Z., N.W. Duijvis, E.W. Vogels, F.H. van Dooren, P.D. Moerland, and A.A. Te Velde. 2014. Effect of interleukin-17 on gene expression profile of fibroblasts from Crohn’s disease patients. Journal of Crohn’s & Colitis. doi:10.​1016/​j.​crohns.​2014.​02.​009.
10.
Zurück zum Zitat Kwa, F.A, and T.R. Thrimawithana. 2014. Epigenetic modifications as potential therapeutic targets in age-related macular degeneration and diabetic retinopathy. Drug Discovery Today. doi:10.1016/j.drudis.2014.03.026. Kwa, F.A, and T.R. Thrimawithana. 2014. Epigenetic modifications as potential therapeutic targets in age-related macular degeneration and diabetic retinopathy. Drug Discovery Today. doi:10.​1016/​j.​drudis.​2014.​03.​026.
11.
Zurück zum Zitat Lam, M., L. Hull, R. McLachlan, K. Snidvongs, D. Chin, E. Pratt, L. Kalish, R. Sacks, P. Earls, W. Sewell, and R.J. Harvey. 2013. Clinical severity and epithelial endotypes in chronic rhinosinusitis. International Forum of Allergy & Rhinology 3: 121–128.CrossRef Lam, M., L. Hull, R. McLachlan, K. Snidvongs, D. Chin, E. Pratt, L. Kalish, R. Sacks, P. Earls, W. Sewell, and R.J. Harvey. 2013. Clinical severity and epithelial endotypes in chronic rhinosinusitis. International Forum of Allergy & Rhinology 3: 121–128.CrossRef
12.
Zurück zum Zitat Li, N., Q. Zhu, Z. Li, Q. Han, G. Zhang, J. Chen, Y. Lv, F. Xing, Y. Chen, X. Zeng, and Z. Liu. 2014. IL17A gene polymorphisms, serum IL-17A and IgE levels, and hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection. Molecular Carcinogenesis 53: 447–457.PubMedCrossRef Li, N., Q. Zhu, Z. Li, Q. Han, G. Zhang, J. Chen, Y. Lv, F. Xing, Y. Chen, X. Zeng, and Z. Liu. 2014. IL17A gene polymorphisms, serum IL-17A and IgE levels, and hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection. Molecular Carcinogenesis 53: 447–457.PubMedCrossRef
13.
Zurück zum Zitat Liu, B., L. Wei, C. Meyerle, J. Tuo, H.N. Sen, Z. Li, S. Chakrabarty, E. Agron, C.C. Chan, M.L. Klein, E. Chew, F. Ferris, and R.B. Nussenblatt. 2011. Complement component C5a promotes expression of IL-22 and IL-17 from human T cells and its implication in age-related macular degeneration. Journal of Translational Medicine 9: 1–12.PubMedCrossRef Liu, B., L. Wei, C. Meyerle, J. Tuo, H.N. Sen, Z. Li, S. Chakrabarty, E. Agron, C.C. Chan, M.L. Klein, E. Chew, F. Ferris, and R.B. Nussenblatt. 2011. Complement component C5a promotes expression of IL-22 and IL-17 from human T cells and its implication in age-related macular degeneration. Journal of Translational Medicine 9: 1–12.PubMedCrossRef
14.
Zurück zum Zitat Maalmi, H., A. Beraies, R. Charad, J. Ammar, K. Hamzaoui, and A. Hamzaoui. 2014. IL-17A and IL-17F genes variants and susceptibility to childhood asthma in Tunisia. The Journal of Asthma: Official Journal of the Association for the Care of Asthma 51: 348–354.CrossRef Maalmi, H., A. Beraies, R. Charad, J. Ammar, K. Hamzaoui, and A. Hamzaoui. 2014. IL-17A and IL-17F genes variants and susceptibility to childhood asthma in Tunisia. The Journal of Asthma: Official Journal of the Association for the Care of Asthma 51: 348–354.CrossRef
15.
Zurück zum Zitat Moon, S.J., J.S. Park, Y.J. Woo, M.A. Lim, S.M. Kim, S.Y. Lee, E.K. Kim, H.J. Lee, W.S. Lee, S.H. Park, J.H. Jeong, S.H. Park, H.Y. Kim, M.L. Cho, and J.K. Min. 2014. Rebamipide suppresses collagen-induced arthritis through reciprocal regulation of th17/treg cell differentiation and heme oxygenase 1 induction. Arthritis and Rheumatology (Hoboken, N.J.) 66: 874–885.CrossRef Moon, S.J., J.S. Park, Y.J. Woo, M.A. Lim, S.M. Kim, S.Y. Lee, E.K. Kim, H.J. Lee, W.S. Lee, S.H. Park, J.H. Jeong, S.H. Park, H.Y. Kim, M.L. Cho, and J.K. Min. 2014. Rebamipide suppresses collagen-induced arthritis through reciprocal regulation of th17/treg cell differentiation and heme oxygenase 1 induction. Arthritis and Rheumatology (Hoboken, N.J.) 66: 874–885.CrossRef
16.
Zurück zum Zitat Ng, T.K., V.R. Fortino, D. Pelaez, and H.S. Cheung. 2014. Progress of mesenchymal stem cell therapy for neural and retinal diseases. World Journal of Stem Cells 6: 111–119.PubMedCentralPubMedCrossRef Ng, T.K., V.R. Fortino, D. Pelaez, and H.S. Cheung. 2014. Progress of mesenchymal stem cell therapy for neural and retinal diseases. World Journal of Stem Cells 6: 111–119.PubMedCentralPubMedCrossRef
17.
Zurück zum Zitat Ocejo-Vinyals, J.G., E.P. de Mateo, M.A. Hoz, J.L. Arroyo, R. Aguero, F. Ausin, and M.C. Farinas. 2013. The IL-17G-152A single nucleotide polymorphism is associated with pulmonary tuberculosis in northern Spain. Cytokine 64: 58–61.PubMedCrossRef Ocejo-Vinyals, J.G., E.P. de Mateo, M.A. Hoz, J.L. Arroyo, R. Aguero, F. Ausin, and M.C. Farinas. 2013. The IL-17G-152A single nucleotide polymorphism is associated with pulmonary tuberculosis in northern Spain. Cytokine 64: 58–61.PubMedCrossRef
18.
Zurück zum Zitat Omrane, I., R. Marrakchi, O. Baroudi, A. Mezlini, H. Ayari, I. Medimegh, N. Stambouli, N. Kourda, H. Bouzaienne, N. Uhrhammer, K. Bougatef, Y.J. Bignon, and A. Benammar-Elgaaied. 2014. Significant association between interleukin-17A polymorphism and colorectal cancer. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine. doi:10.1007/s13277-014-1890-4. Omrane, I., R. Marrakchi, O. Baroudi, A. Mezlini, H. Ayari, I. Medimegh, N. Stambouli, N. Kourda, H. Bouzaienne, N. Uhrhammer, K. Bougatef, Y.J. Bignon, and A. Benammar-Elgaaied. 2014. Significant association between interleukin-17A polymorphism and colorectal cancer. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine. doi:10.​1007/​s13277-014-1890-4.
19.
Zurück zum Zitat Qinghai, Z., W. Yanying, C. Yunfang, Z. Xukui, and Z. Xiaoqiao. 2014. Effect of interleukin-17A and interleukin-17F gene polymorphisms on the risk of gastric cancer in a Chinese population. Gene 537: 328–332.PubMedCrossRef Qinghai, Z., W. Yanying, C. Yunfang, Z. Xukui, and Z. Xiaoqiao. 2014. Effect of interleukin-17A and interleukin-17F gene polymorphisms on the risk of gastric cancer in a Chinese population. Gene 537: 328–332.PubMedCrossRef
20.
Zurück zum Zitat Sato, D.K., I. Nakashima, A. Bar-Or, T. Misu, C. Suzuki, S. Nishiyama, H. Kuroda, K. Fujihara, and M. Aoki. 2014. Changes in Th17 and regulatory T cells after fingolimod initiation to treat multiple sclerosis. Journal of Neuroimmunology 268: 95–98.PubMedCrossRef Sato, D.K., I. Nakashima, A. Bar-Or, T. Misu, C. Suzuki, S. Nishiyama, H. Kuroda, K. Fujihara, and M. Aoki. 2014. Changes in Th17 and regulatory T cells after fingolimod initiation to treat multiple sclerosis. Journal of Neuroimmunology 268: 95–98.PubMedCrossRef
21.
Zurück zum Zitat Taylor, P.R., S. Roy, S.M. Leal Jr., Y. Sun, S.J. Howell, B.A. Cobb, X. Li, and E. Pearlman. 2014. Activation of neutrophils by autocrine IL-17A-IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORgammat and dectin-2. Nature Immunology 15: 143–151.PubMedCentralPubMedCrossRef Taylor, P.R., S. Roy, S.M. Leal Jr., Y. Sun, S.J. Howell, B.A. Cobb, X. Li, and E. Pearlman. 2014. Activation of neutrophils by autocrine IL-17A-IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORgammat and dectin-2. Nature Immunology 15: 143–151.PubMedCentralPubMedCrossRef
22.
Zurück zum Zitat Wei, L., B. Liu, J. Tuo, D. Shen, P. Chen, Z. Li, X. Liu, J. Ni, P. Dagur, H.N. Sen, S. Jawad, D. Ling, S. Park, S. Chakrabarty, C. Meyerle, E. Agron, F.L. Ferris 3rd, E.Y. Chew, J.P. McCoy, E. Blum, P.J. Francis, M.L. Klein, R.H. Guymer, P.N. Baird, C.C. Chan, and R.B. Nussenblatt. 2012. Hypomethylation of the IL17RC promoter associates with age-related macular degeneration. Cell Reports 2: 1151–1158.PubMedCentralPubMedCrossRef Wei, L., B. Liu, J. Tuo, D. Shen, P. Chen, Z. Li, X. Liu, J. Ni, P. Dagur, H.N. Sen, S. Jawad, D. Ling, S. Park, S. Chakrabarty, C. Meyerle, E. Agron, F.L. Ferris 3rd, E.Y. Chew, J.P. McCoy, E. Blum, P.J. Francis, M.L. Klein, R.H. Guymer, P.N. Baird, C.C. Chan, and R.B. Nussenblatt. 2012. Hypomethylation of the IL17RC promoter associates with age-related macular degeneration. Cell Reports 2: 1151–1158.PubMedCentralPubMedCrossRef
23.
Zurück zum Zitat Yu, H., X. Zou, L. Peng, Y. Wang, C. Zhang, B. Chen, and Y. Zou. 2013. Effect of soluble inducible costimulator level and its polymorphisms on age-related macular degeneration. DNA and Cell Biology 32: 717–721.PubMedCentralPubMedCrossRef Yu, H., X. Zou, L. Peng, Y. Wang, C. Zhang, B. Chen, and Y. Zou. 2013. Effect of soluble inducible costimulator level and its polymorphisms on age-related macular degeneration. DNA and Cell Biology 32: 717–721.PubMedCentralPubMedCrossRef
24.
Zurück zum Zitat Yu, X.H., N. Jiang, X.L. Zheng, F.S. Cayabyab, Z.B. Tang, and C.K. Tang. 2014. Interleukin-17A in lipid metabolism and atherosclerosis. Clinica Chimica Acta; International Journal of Clinical Chemistry 431C: 33–39.CrossRef Yu, X.H., N. Jiang, X.L. Zheng, F.S. Cayabyab, Z.B. Tang, and C.K. Tang. 2014. Interleukin-17A in lipid metabolism and atherosclerosis. Clinica Chimica Acta; International Journal of Clinical Chemistry 431C: 33–39.CrossRef
Metadaten
Titel
Genetic Variants of Interleukin 17A Are Functionally Associated with Increased Risk of Age-Related Macular Degeneration
verfasst von
Shaoru Zhang
Yonghua Liu
Shilin Lu
Xinmeng Cai
Publikationsdatum
01.04.2015
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 2/2015
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-014-9973-3

Weitere Artikel der Ausgabe 2/2015

Inflammation 2/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.